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Abstract
Introduction: Host immunity should play a principal role in determining both the outcome and recovery of
patients with sepsis that originated from a microbial infection. Quantification of the levels of key elements of the
immune response could have a prognostic value in this disease.
Methods: In an attempt to evaluate the quantitative changes in the status of immunocompetence in severe sepsis
over time and its potential influence on clinical outcome, we monitored the evolution of immunoglobulins (Igs)
(IgG, IgA and IgM), complement factors (C3 and C4) and lymphocyte subsets (CD4+ T cells, CD8+ T cells, B cells
(CD19+) and natural killer (NK) cells (CD3-CD16+CD56+)) in the blood of 50 patients with severe sepsis or septic
shock at day 1, day 3 and day 10 following admission to the ICU.
Results: Twenty-one patients died, ten of whom died within the 72 hours following admission to the ICU. The
most frequent cause of death (n = 12) was multiorgan dysfunction syndrome. At day 1, survivors showed
significantly higher levels of IgG and C4 than those who ultimately died. On the contrary, NK cell levels were
significantly higher in the patients who died. Survivors exhibited a progressive increase from day 1 to day 10 on
most of the immunological parameters evaluated (IgG, IgA, IgM, C3, CD4+, CD8+ T cells and NK cells). Multivariate
Cox regression analysis, including age, sex, APACHE II score, severe sepsis or septic shock status and each one of
the immunological parameters showed that NK cell counts at day 1 were independently associated with increased
risk of death at 28 days (hazard ratio = 3.34, 95% CI = 1.29 to 8.64; P = 0.013). Analysis of survival curves provided
evidence that levels of NK cells at day 1 (> 83 cells/mm3) were associated with early mortality.
Conclusions: Our results demonstrate the prognostic role of NK cells in severe sepsis and provide evidence for a
direct association of early counts of these cells in blood with mortality.
Introduction
Severe sepsis (acute organ dysfunction secondary to
infection) and septic shock (severe sepsis plus hypoten-
sion not reversed by fluid resuscitation) are major
healthcare problems that affect millions of individuals
around the world each year, killing one in four (and
often more) and increasing in incidence [1-3]. Similarly
to polytrauma, acute myocardial infarction and stroke,
the early initiation of therapy once severe sepsis is estab-
lished is likely to influence the patient’s prognosis. In
consequence, early identification of individuals at risk
for bad outcomes is dramatically important in this con-
dition [4].
Because sepsis originates from a microbial infection,
host immunity should play a principal role in determin-
ing both outcome and recovery. A protective role of
naturally produced immunoglobulin G (IgG) in sepsis
was described previously [5]. The participation of cellu-
lar immunity in this disease is poorly understood, and
the available data are controversial [6-8].
Identifying quantitative alterations in key humoral and
cellular parameters could have a prognostic value in this
condition. In an attempt to evaluate the quantitative
changes in the status of immunocompetence in severe
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sepsis over time and its potential influence on clinical
outcome, we monitored levels of blood of Immunoglo-
bulins (IgG, IgA and IgM), complement factors (C3 and
C4), lymphocyte subpopulations (T, B and natural killer
(NK) cells) in 50 consecutive patients with a diagnosis
of severe sepsis or septic shock at three moments during
their hospitalization in the ICU. Our measurement of
these parameters provide a first assessment of the status
of both humoral and cellular arms of the immune
response, and their evaluation is easily available in the
vast majority of hospitals with critical care medicine
units.
Materials and methods
Patients
Inclusion criteria
Patients ages 18 years and older with a diagnosis of
severe sepsis or septic shock upon admission to our
ICU were prospectively and consecutively recruited
from January 2010 to January 2011. The first day follow-
ing ICU admission was considered day 1 in the analysis.
‘Sepsis’ was defined as suspected infection in the pre-
sence of two or more systemic inflammatory response
syndrome criteria [9]. ‘Severe sepsis’ was defined as sep-
sis plus sepsis-induced organ dysfunction or tissue
hypoperfusion [10]. Sepsis-induced hypotension was
defined as systolic blood pressure (SBP) < 90 mmHg,
mean arterial pressure < 70 mmHg or SBP decrease >
40 mmHg or < 2 SD below normal for age in the
absence of other causes of hypotension. ‘Septic shock’
was defined as hypotension (SBP < 90 mmHg) despite
adequate fluid resuscitation (> 1,500 ml) or the use of
vasoactive agents [10]. Severity of illness was assessed
on the basis of two scores: the Acute Physiology and
Chronic Health Evaluation II (APACHE II) score for the
first 24 hours following diagnosis [11] and the Sequen-
tial Organ Failure Assessment (SOFA) score [12].
Exclusion criteria
Exclusion criteria were the presence of immunodefi-
ciency or concomitant immunosuppressive therapy,
pregnancy, do not resuscitate status and cardiac arrest.
Approval of the study protocol for both the scientific
and ethical aspects was obtained from the Scientific
Committee for Clinical Research of our hospital.
Informed consent was obtained directly from each
patient or his or her legal representative before
enrolment.
Microbiological diagnostics
Standard cultures in biological samples guided by the
presumptive source of the septic insult were performed
to assess the presence of bacterial and fungal infection
[13], along with detection of a urinary antigen test for
Legionella pneumophila or Streptococcus pneumoniae. In
addition, two consecutive identifications by the LightCy-
cler SeptiFast Test MGRADE (Roche Molecular Diag-
nostics, Pleasanton, CA, USA) real-time PCR in blood
were also considered a positive result. Potentially con-
taminant microorganisms were not considered.
Immunological laboratory workup
A serum sample was collected from each patient at day
1, day 3 and day 10 following admission to the ICU.
IgG, IgM, IgA, C3 and C4 levels in serum were mea-
sured by using a Dade Behring BN II System nephel-
ometer (Siemens Healthcare Diagnostics, Deerfield, IL,
USA). A blood sample was collected in parallel by using
tubes containing ethylenediaminetetraacetic acid. Quan-
tification of lymphocytes subpopulations was performed
by using BD Trucount tubes (BD Biosciences, San Jose,
CA, USA) for enumeration of mature human T (CD3+),
B (CD19+), helper/inducer T (CD3+CD4+), suppressor/
cytotoxic T (CD3+CD8+) and NK (CD3-CD16+CD56+)
lymphocytes by using a BD FACSCalibur 4-color flow
cytometer (342975; BD Biosciences).
Statistical analysis
Comparison of immune parameters levels based upon
mortality were performed using the Mann-Whitney U
test. Differences in the levels of immune parameters
over the observation period were assessed using the
Wilcoxon signed-rank test. We determined the HR and
95% CI by Cox regression analysis, which was used to
assess the impact of independent variables on mortality
over time. Multivariate analysis, including age, sex,
APACHE II score, severe sepsis or septic shock status
and each one of the immunological parameters, was per-
formed. These variables were checked for colinearity
prior to inclusion in the regression models using Toler-
ance and Variance Inflation Factor. We determined the
occurrence of death by using Kaplan-Meier curves.
Groups were compared by using the log-rank test (Man-
tel-Haenzel). Logarithmic concentrations of the immune
parameters evaluated were employed in the regression
analysis to satisfy the linearity assumption. All statistical
tests were two-sided, and P < 0.05 was considered sig-
nificant. Data analysis was performed using SPSS for
Windows version 15.0 software (SPSS, Chicago, IL,
USA).
Results
Clinical characteristics of the patients
The majority of the patients of our cohort were elderly
and male, with nonsurvivors being older than survivors
(Table 1). The most common comorbidities were cardi-
ovascular disease, diabetes and arterial hypertension.
Chronic obstructive pulmonary disease was present in
many patients who ultimately died during their ICU
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hospitalization. Eight patients had an antecedent of solid
organ neoplasia with criteria of cure. None of these
patients were received chemotherapy or showed evi-
dence of metastasis at the time of admission. Septic
shock was the most frequent cause of admission to the
ICU, mostly in the group who eventually died. The prin-
cipal suspected source of infection was the lower
respiratory tract. The presence of a microorganism was
documented in 72% of the cases, with a balanced pro-
portion of Gram-positive and Gram-negative bacteria.
Two patterns of mortality were observed in our cohort:
a group of patients (n = 10) died within the 72 hours
following admission to the ICU and a group of patients
(n = 11) who died later than day 3. All but one of the
patients who died presented at admission with status of
septic shock. The most frequent cause of death (n = 12)
was multiorgan dysfunction syndrome. Refractory shock,
refractory hypoxemia and cardiovascular events were the
causes of the death in the remaining fatal cases. Five
nonsurvivors and three survivors received corticoster-
oids as part of their severe sepsis management. All these
patients presented with septic shock, and steroids were
administered after the first 24 hours of their ICU stay
(hydrocortisone (50 mg/6 hours or 100 mg/8 hours
intravenously).
Comparison of immunological parameters levels based
upon outcome
At day 1, survivors showed significantly higher levels of
IgG and C4 than those who died during hospitalization
in the ICU (Table 2). On the contrary, NK cell absolute
counts were significantly higher in the group of patients
who died. The relative concentrations of NK cells in
blood (percentage of total lymphocytes) were also higher
in the group of nonsurvivors (median (IQR): survivors =
was 9 (12.5) and nonsurvivors = 20 (24.5); P < 0.05).
Table 1 Demographics and clinical characteristics of the patients based upon ICU mortality
Demographic and clinical characteristics Survivors
(n = 29)
Nonsurvivors
(n = 21)
Total population
(n = 50)
Survivors vs nonsurvivors
P value
Age (years) 66.0 (20.0) 72.0 (14) 68.5 (19.2) 0.048
Males 18 (62%) 14 (66.6%) 32 (64%) n.s.
APACHE II score at ICU admission 18.0 (15.0) 23.0 (10.0) 20.5 (13.2) n.s.
SOFA score at ICU admission 7.0 (6.0) 9.0 (2.0) 8.0 (4.0) n.s.
Comorbidities
Cardiovascular disease 8 (26.6%) 7 (35%) 15 (30%) n.s.
COPD 2 (6.6%) 6 (30%) 8 (16%) 0.025
Chronic renal failure or dialysis 2 (6.6%) 2 (10%) 4 (8%) n.s.
Diabetes mellitus types 1 and 2 10 (33.3%) 7 (35%) 17 (34%) n.s.
Alcohol abuse 2 (6.6%) 1 (5%) 3 (6%) n.s.
Hypertension 12 (41.3%) 7 (33.3%) 19 (38%) n.s.
Neoplasia 3 (10%) 5 (25%) 8 (16%) n.s.
Obesity 2 (6.6%) 1 (5%) 3 (6%) n.s.
Diagnostic at ICU admission
Severe sepsis 11 (36.6%) 1 (5%) 12 (24%) 0.007
Septic shock 18 (62%) 20 (95.2%) 38 (76%) 0.007
Presumed source of infection
Lower respiratory tract/pneumonia 14 (46.6%) 9 (45%) 23 (46%) n.s.
Urogenital 6 (20%) 3 (15%) 9 (18%) n.s.
Intra-abdominal 2 (6.6%) 3 (15%) 5 (10%) n.s.
Catheter- or device-related 1 (3.3%) 1 (5%) 2 (4%) n.s.
Skin (soft tissues) 2 (6.6%) 1 (5%) 3 (6%) n.s.
Prosthesis 2 (6.6%) 0 (0%) 2 (4%) n.s.
Central nervous system 1 (3.3%) 0 (0%) 1 (2%) n.s.
Other/unknown 2 (6.8%) 4 (19%) 6 (12%) n.s.
Documented microbial agent
Gram-positive 8 (26%) 6 (30%) 14 (28%) n.s.
Gram-negative 10 (34.4%) 9 (42.8%) 19 (38%) n.s.
Fungi 2 (6.6%) 1(5%) 3 (6%) n.s.
Continuous variables are expressed as medians (IQR). All other data are raw numbers (%). Proportions were compared using the Χ2 test or Fisher’s exact test
where appropriate. APACHE II: Acute Physiology and Chronic Health Evaluation II; COPD: chronic obstructive pulmonary disease; SOFA: sequential organ failure
assessment score; n.s. = not significant.
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Comparison of immune parameters levels at day 3 evi-
denced higher levels of IgG in those patients who sur-
vived (Table 2). No differences were found at this
moment in the course of the disease for the other para-
meters compared (Table 2). When comparisons were
repeated considering only those patients with septic
shock (n = 38), the same results were obtained (Addi-
tional file 1). Survivors exhibited a progressive increase
from day 1 to day 10 on most of the immunological
parameters evaluated (IgG, IgA, IgM, C3, CD4+, CD8+
T cells and NK cells) (Additional file 2).
Immune parameters and prediction of mortality
Multivariate Cox regression analysis showed that NK
cell counts at day 1 were independently associated with
increased risk of death at 28 days. The median outcome
of death at day 28 was 3.34 (95% CI = 1.29 to 8.64; P =
0.013). Analysis of the survival curves evidenced that
levels of NK cells at day 1 (> 83 cells/mm3) were asso-
ciated with early mortality (Figure 1).
When multivariate regression analysis was repeated
considering only septic shock patients, NK cell counts at
day 1 remained a risk factor for mortality (HR = 3.20,
95% CI = 1.23 to 8.35; P = 0.017). IgG levels at day 1
showed a protective association with increased survival
at day 28 which was close to statistical significance (HR
= 0.10, (95% CI = 0.01 to 1.15; P = 0.065).
Discussion
Our results provide evidence that differences in the sys-
temic levels of a number of key host immunity elements
in patients with severe sepsis influence their final out-
come. Compared to those patients who survived, septic
patients who died showed lower levels of IgG and C4,
along with higher levels of NK cells, in the first 24
hours following admission to the ICU. Comparisons
between fatal cases and survivors, as well as the results
of our regression analysis, suggest that NK cell counts at
day 1 are associated with increased risk of mortality in
patients who present to the ICU with severe sepsis. The
role of these cells in sepsis is controversial [14]. NK-cell
depletion increases survival and decreases systemic
levels of cytokines in experimental models of sepsis
[7,15-21]. In humans, available data derived from
patients in the ICU are scarce, and some of them
diverge with the results derived from animal models.
Gogos et al. [22] found increased absolute counts of NK
cells in sepsis caused by community-acquired pneumo-
nia. Giamarellos-Bourboulis et al. [8] reported improved
survival in patients with severe Gram-negative sepsis
and high NK counts. NK cells have sophisticated biolo-
gical functions [23], participating with antigen presenta-
tion cells and T cells in the cellular response against
pathogens. NK cells are key actors in innate immunity
and as a consequence should play an important role in
the very early moments of sepsis. In addition, NK cells
could release high amounts of proinflammatory cyto-
kines such as IFN-g or immunosuppressive agents, such
as IL-10, thus promoting tissue damage and interfering
with the development of the adaptive immune response
against the causative microbial agent [23].
When we performed a subanalysis considering only
those patients with septic shock, NK cell counts at day
1 were still associated with increased risk of mortality.
On the contrary, IgG levels at day 1 showed a protective
trend close to statistical significance in the regression
analysis. Taccone et al. [5] reported low concentrations
of IgG as a common finding in patients with
Table 2 Comparison of immunological parameters based upon ICU mortality
ICU mortality from day 1
(N = 50)
ICU mortality from day 3
(N = 40)
ICU mortality from day 10
(N = 37)
Immunological parameters Survivors
(n = 29)
Nonsurvivors
(n = 21)
P value Survivors
(n = 29)
Nonsurvivors
(n = 11)
P value Survivors
(n = 28)
Nonsurvivors
(n = 9)
P
value
IgG (mg/dl) 844.0 (447.5) 616.0 (442.5) 0.035 932.0 (371.0) 685.0 (538.0) 0.007 1,080.0 (602.2) 764.0 (1068.0) n.s.
IgA (mg/dl) 240.0 (128.0) 184.0 (167.0) n.s. 280.0 (144.0) 240.0 (209.0) n.s. 334.0 (164.0) 257.0 (580.8) n.s.
IgM (mg/dl) 53.0 (47.0) 60.0 (53.0) n.s. 70.0 (85.0) 67.0 (61.0) n.s. 79.5 (66.5) 42.0 (86.0) n.s.
C3 (mg/dl) 101.5 (52.3) 79.0 (60.5) n.s. 108.0 (55.0) 110.0 (89.0) n.s. 135.0 (49.0) 106.0 (81.0) n.s.
C4 (mg/dl) 24.0 (19.0) 17.0 (16.0) 0.029 24.0 (16.5) 28.0 (22.0) n.s. 32.0 (18.0) 20.0 (10.0) n.s.
CD3+ T (cells/mm3) 417.0 (706.5) 419.0 (585.0) n.s. 639.5 (636.3) 472.0 (415.0) n.s. 774.0 (463.5) 561.0 (552.0) n.s.
CD4+ T (cells/mm3) 288.0 (474.5) 198.0 (400.0) n.s. 372.5 (525.8) 366.0 (423.0) n.s. 519.0 (339.0) 347.0 (355.0) n.s.
CD8+ T (cells/mm3) 114.0 (258.0) 156.0 (231.0) n.s. 249.5 (199.0) 120.0 (145.0) n.s. 287.0 (296.0) 204.0 (314.0) n.s.
CD4+ CD8+ T (cells/mm3) 5.0 (12.0) 6.0 (13.5) n.s. 5.0 (9.0) 6.5 (24.0) n.s. 12.0 (18.3) 6.0 (54.0) n.s.
LB (cells/mm3) 103.0 (165.5) 184.0 (281.0) n.s. 163.0 (125.0) 127.0 (168.0) n.s. 118.0 (151.0) 92.0 (131.0) n.s.
NK (cells/mm3) 56.8 (59.5) 98.0 (392.0) 0.050 59.5 (72.5) 42.0 (73.0) n.s. 86.0 (78.0) 92.0 (38.0) n.s.
Data are expressed as medians (IQR). n.s. = not significant. Normal values in adult healthy individuals are as follows: immunoglobulin G (IgG) = 870 to 2,180 mg/
dl, IgA = 117 to 420 mg/dl; IgM = 60 to 220 mg/dl; CD3+ T cells = 690 to 2,540 cells/mm3; CD4+ T cells = 410 to 1,590 cells/mm3; CD8+ T cells = 190 to 1,140
cells/mm3; CD4+ CD8+ T cells = not available; B lymphocytes (LB) = 90 to 660 cells/mm3; natural killer (NK) cells = 90 to 590 cells/mm3; complement factor 3 (C3)
= 50 to 120 mg/dl; complement factor 4 (C4) = 14 to 70 mg/dl.
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community-acquired septic shock. In their study,
patients with hypo-IgG had greater vasopressor require-
ments, were more likely to develop acute lung injury
and/or acute respiratory distress syndrome and had
higher mortality. Studies with larger numbers of patients
are necessary to confirm the protective trend of IgG in
this disease.
The relatively lower levels of C4 observed in patients
who died in our study could be a consequence of con-
sumption of this complement in severe sepsis. In agree-
ment with our results, Nakae et al. [24] found
significantly lower levels of C3 and C4 in septic patients
who did not survive than in those who did. Analysis of
the variations over time in the levels of the immunologi-
cal parameters evaluated showed that most survivors
exhibited a progressive increase from day 1 to day 10 in
most of the parameters. This result provides evidence
for a compromised host response during the very first
moments of severe sepsis (at least from the quantitative
point of view) which improves at the latter stages of the
disease in these patients. Interestingly, nonsurvivors
failed to show significant increments in the levels of the
immune parameters measured over time. These findings
warrant further work with larger cohorts of patients to
evaluate the inclusion of immunological parameters as
part of the severity scores in sepsis. A limitation of our
study is the definition employed for NK cells (CD3-
CD16+CD56+ lymphocytes), since it did not include a
subset of CD16- NK cells, which account for a minor
percentage of total NK cells (5% to 10%). Nonetheless,
the definition used in this work identified the largest
population of these cells.
Conclusions
Our results demonstrate the prognostic role of NK
cells (defined as CD3-CD16+CD56+ lymphocytes) in
severe sepsis, proving a direct association of early
blood counts of these cells with mortality. Further stu-
dies including functional analysis of NK cells are
needed to confirm their exact role in the pathogenesis
of this disease.
Key messages
◆ Being that sepsis originates from a microbial infec-
tion, host immunity should play a principal role in
determining both outcome and recovery. Identifying
quantitative alterations in key humoral and cellular
parameters could have a prognostic value in this
disease.
◆ Compared to survivors, septic patients who did
not survive showed lower levels of IgG and C4 and
higher levels of NK cells in blood in the first 24
hours following admission to the ICU.
◆ Kaplan Meier curves and Cox regression analysis
demonstrate the prognostic role of NK cells (defined
as (CD3-CD16+CD56+) lymphocytes) in severe sep-
sis, evidencing a direct association of early blood
counts of these cells with mortality.
Figure 1 Kaplan-Meier curves. Deciles from percentile 10 to percentile 90 of natural killer (NK) cell counts measured at day 1 were calculated
and used to compare survival times in those patients with low or high concentrations of NK cells in their blood. The first decile shows
significant differences between groups based upon the log-rank test (Mantel-Haenzel) and was used as the cutoff (percentile 60 (83 cells/mm3)).
Outcome for this analysis was time until death. Time was censored at day 28. Cum Surv: cumulative survivors; NK: natural killer.
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Additional material
Additional file 1: Comparison of immunological parameters based
upon ICU mortality in patients with septic shock. Data are medians
[IQR]. n.s = not significant. Normal values in healthy adults are as follows:
immunoglobulin G (IgG) = 870 to 2,180 mg/dl; IgA = 117 to 420 mg/dl;
IgM = 60 to 220 mg/dl; CD3+ T cells = 690 to 2,540 cells/mm3; CD4+ T
cells = 410 to 1,590 cells/mm3; CD8+ T cells = 190 to 1,140 cells/mm3;
CD4+CD8+ T cells = not available; B lymphocytes (LB) = 90 to 660 cells/
mm3; natural killer (NK) cells = 90 to 590 cells/mm3; complement factor 3
(C3) = 50 to 120 mg/dl; complement factor 4 (C4) = 14 to 70 mg/dl.
Additional file 2: Comparison of immunological parameter levels
over time. Changes in the levels of immune parameters over time in
survivors and nonsurvivors were assessed using the Wilcoxon signed-rank
test. The results are expressed as medians (IQR) of the increments (day 3
- day 1) and (day 10 - day 1). IgG = immunoglobulin G; IgM =
immunoglobulin M; IgA = immunoglobulin A; C3: complement factor 3;
C4: complement factor 4; NK cells: natural killer cells; LB = B lymphocytes.
Abbreviations
APACHE II: Acute Physiology and Chronic Health Evaluation II; C3:
complement factor 3; C4: complement factor 4; CD: cluster differentiation;
COPD: chronic obstructive pulmonary disease; HR: hazard ratio; IFN-γ:
interferon γ; Ig: immunoglobulin; IL: interleukin; LB: B lymphocyte: NK: natural
killer; PCR: polymerase chain reaction; SBP: systolic blood pressure; SOFA:
Sequential Organ Failure Assessment.
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